PCI or CABG for Left Main Disease: Does Disease Location Matter?
Manu Rajachandran1, Rakhee Makhija2
1Division of Cardiology, Medicine/Cardiology, Department of Internal Medicine, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center, Associate Professor, El Paso, TX, USA. m.rajachandran@ttuhsc.edu.
Current Cardiology Reports
|January 17, 2022
Summary
Percutaneous coronary intervention and coronary artery bypass surgery show similar mortality for left main disease. However, left main disease location impacts long-term outcomes more with percutaneous coronary intervention, suggesting a personalized treatment approach.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
Background:
- Management of left main coronary artery disease has evolved, challenging traditional surgical revascularization.
- Drug-eluting stent advancements enable percutaneous coronary intervention as a viable alternative to coronary artery bypass surgery.
Purpose of the Study:
- To evaluate the impact of left main disease location on mortality and cardiovascular outcomes.
- To compare percutaneous coronary intervention (PCI) versus coronary artery bypass surgery (CABG) for left main disease.
Main Methods:
- Systematic review of studies comparing PCI and CABG for left main disease.
- Analysis of mortality and cardiovascular outcomes based on disease location.
Main Results:
- Overall mortality rates are comparable between PCI and CABG for left main disease.
- Left main disease location significantly influences long-term outcomes in PCI patients more than in CABG patients.
- A patient- and lesion-centered approach is recommended for optimal treatment outcomes.
Conclusions:
- PCI is a competitive alternative to CABG for left main disease, with comparable short-term mortality.
- Long-term outcomes are influenced by lesion complexity and location, necessitating individualized treatment strategies.
- Further research into patient- and lesion-specific factors is crucial for optimizing left main revascularization.
Related Concept Videos
01:24Cardiac Catheterization III: Left Heart Catheterization
255
Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
255
01:27Coronary Artery Disease V: Interprofessional Care
58
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
58
01:29Cardiomyopathy V: Interprofessional Care
59
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
59
01:21Cardiac Catheterization II: Right Heart Catheterization
228
Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
228
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
84
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
84
01:28Cardiac Catheterization I: Pre-Procedure Overview
232
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
232